Type IX collagen: A possible function in articular cartilage  by Wotton, S.F. et al.
Volume 234, number 1, 79-82 FEB 06004 July 1988 
Type IX collagen: a possible function in articular cartilage 
S.F. Wotton, V.C. Duance and P.R. Fryer* 
AFRC Institute of Food Research, Bristol Laboratory, Langford. Bristol, Avon BS18 7DY and *Clinical Research Centre, 
Watford Road, Harrow, Middlesex, England 
Received 29 March 1988 
The effect of type IX on in vitro fibrillogenesis of type II collagen indicated that, while not preventing fibrillogenesis, 
the presence of type IX collagen reduced the size of the type II fibre aggregates. This observation is consistent with the 
in vivo localisation studies of type IX collagen. Using the immunogold labelling technique, type IX collagen was shown 
to be located evenly on small fibrils which occur at higher concentration closer to the cell. Therefore type IX collagen 
may function as a regulator of fibre diameter in articular cartilage. 
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1. INTRODUCTION 
Type IX collagen is one of several minor col- 
lagens found in articular cartilage. Considerable 
structural information has now been determined 
for both the avian and the mammalian molecules 
[l-5]. 
The molecule is composed of three distinct LY- 
chains, two having molecular masses of 68 kDa 
and the third of 84 kDa [6]. There are three col- 
lagenous domains interrupted by short non-triple 
helical sequences and the al-chain has a large 
globular N-terminal domain. One of the 68 kDa 
molecular mass chains, the a2-chain, has covalent- 
ly linked glycosaminoglycans and migrates with a 
molecular mass around 115 kDa before treatment 
with chondroitinase ABC [7]. 
Immunohistochemical localisation studies have 
shown that in mature mamrnalian articular car- 
tilage type IX is preferentially located in the 
pericellular region of the chondrocyte [8,9]. In 
contrast, studies on chick sternal cartilage have 
revealed a more even distribution throughout the 
tissue [lo]. It has been suggested that the 
Correspondenceaddress: S.F. Wotton, AFRC Institute of Food 
Research, Bristol Laboratory, Langford, Bristol, Avon 
BS18 7DY, England 
pericellular staining is an artefact of inadequate 
removal of proteoglycans by hyaluronidase treat- 
ment prior to antibody labelling and that the 
thickness of the section may contribute to this 
artefact. However, recent studies by Poole et al. 
[ 1 I] have shown that the chondrocyte is enclosed in 
a basket-like capsule together comprising a struc- 
ture termed the chondron. We have isolated intact 
chondrons from both mature pig articular cartilage 
and rat chondrosarcoma and shown that these 
structures stain very intensely with antibodies to 
type IX collagen [12]. 
In this paper we present evidence for the func- 
tion of type IX collagen from in vitro 
fibrillogenesis studies. These findings are consis- 
tent with our immunogold labelling experiments 
which show that type IX collagen is localised 
primarily to thin fibres which are more prevalent in 
close proximity to the chondrocyte. 
2. MATERIALS AND METHODS 
2.1. In vitro fibrillogenesis 
Type II and type IX collagen were prepared from rat chon- 
drosarcoma as described [4]. These were dissolved in 0.005 M 
acetic acid at I mg/ml and the solutions clarified by centrifuga- 
tion at 10000 x g for 30 min. Clarified solutions were incubated 
at 4°C and brought to pH 7.4 by the addition of 4 x PBS. The 
type 11 and type IX solutions were mixed in varying amounts 
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ranging from O-15% type IX collagen. Fibre formation was 
carried out by incubating the mixtures at 37°C overnight. Fibres 
were viewed by phase contrast and electron microscopy after 
staining with phosphotungstic acid. Fibre diameters were 
measured from the micrographs using a Mitutoyo Profile Pro- 
Fig.1. In vitro fibrillogenesis. Phase contrast microscopy of 
type II collagen fibres: (A) in the absence of type IX; (9) type 
1l:type 1X ratio 75: I; (C)type 1I:type IX ratio 7.5: 1 (X 290). 
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Table I 
Fibre size during fibrillogenesis 
Small 
fibrils 
(nm) 
Small 
fibres 
(nm) 
Large 
aggregate 
(visual 
score 1-5) 
Type II 4.6 f 0.5 140-360 5 
Type II + IX 75: 1 6.3 + 0.8 11 O-240 3 
Type II + IX 7.5: 1 5.2 + 0.6 50-l 10 1 
Diameters of small fibrils and small fibres measured from 
electron micrographs. Large aggregates scored visually from 
light micrographs (see fig.1). Type IX collagen affected the 
diameter of the small fibres and the large aggregates of type II 
in proportion to the amount of type IX present. No difference 
in the diameter of the small fibrils was apparent 
jector, type PJ250. Samples were analysed by SDS-PAGE using 
the Laemmli method [13] with a 4% stacking gel and 8% 
separating gel. Chondroitinase ABC treatment was carried out 
as described by Konomi et al. [14]. 
2.2. Itnmunogold-labelling of articular cartilage 
Adult pig articular cartilage was cut into 20 gm sections and 
digested with hyaluronidase (1 mg/ml PBS) for 1 h at 37°C 
prior to antibody labelling. Sections were incubated with a 
monoclonal antibody to type IX collagen for 2 h at room 
temperature or with non-immune serum as control. Sections 
were washed with PBS + 1% BSA before incubation with Pro- 
tein A conjugated with 12-14 nm gold particles for 2 h at room 
temperature. After extensive washing in PBS + 1% BSA, sec- 
tions were fixed with 3% glutaraldehyde in cacodylate buffer 
and post-fixed with osmium. After dehydration material was 
embedded in Spurr resin and thin sections cut for viewing in the 
electron microscope. 
3. RESULTS 
In vitro fibrillogenesis experiments using various 
ratios of type II : type IX collagen revealed that as 
the type IX ratio was increased there was a con- 
Table 2 
% alpha 1 (11) in fibrils 
Pellet Supernatant 
Rat type II 55 45 
Rat type II + rat type IX 7.5: 1 85 15 
The presence of type IX collagen increased the percentage of 
type 11 collagen which formed fibres over that remaining 
soluble as measured by densitometry of SDS-polyacrylamide 
gels 
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comitant reduction in the fibre size as observed by 
I phase contrast microscopy (fig. 1). Type II collagen 
alone formed large aggregates which became pro- 
gressively finer as the type IX ratio increased. The 
gross nature of the aggregates made fibre diameter 
j 
measurement difficult and so they were scored on 
a visual basis on an arbitrary scale of 1 to 5 (table 
! 1, column 3). A more precise measure of the fibre 
I diameter was obtained after negative staining and 
s 
electron microscopy. Two types of fibres could be 
identified: small thin fibrils and large, usually 
t banded, fibres. The proportion of the finer fibrils 
F increased with increasing type IX collagen 
? although the size was unaltered (table 1, column 
1). The larger banded fibres, however, were ap- 
proximately 30% the diameter of type II collagen 
alone by the addition of 15% type IX (table 1, col- 
umn 2). 
To see if type IX was actually preventing 
fibrillogenesis, samples were centrifuged and the 
proportion of type II collagen in the pelleted fibres 
and supernatants determined by densitometric 
scanning of SDS-polyacrylamide gels. The results 
showed that type IX collagen actually enhanced 
the proportion of type II collagen which was incor- 
porated into fibres (table 2). Chondroitinase ABC 
treatment of type IX collagen did not affect its 
ability to influence the fibrillogenesis of type II 
collagen. 
The results of the immunogold localisation 
studies are shown in fig.2. Control sections reveal- 
ed no significant background labelling. The an- 
tibody to type IX collagen can be seen to be 
preferentially distributed on the thin fibrillar 
material, with little labelling of the large banded 
fibres. The density of labelling is considerably 
higher in the pericellular region (fig.2B) in com- 
parison with the inter-territorial matrix (fig.2C). 
1 
i 
Fig.2. lmmunogold localisation by electron microscopy of type 
IX collagen. (A) Control localisation with non-specific 
antibody; (B) high concentration of gold label pericellularly; 
localised with monoclonal antibody to type IX; (C) low 
concentration of gold label in inter-territorial matrix; localised 
with monoclonal antibody to type IX (x 28 000, bar = 1 pm). 
4. DISCUSSION 
It is known from histological observations of ar- 
titular cartilage that the pericellular region is com- 
posed of a fine meshwork of fibres whereas the 
inter-territorial matrix contains predominantly 
large fibre bundles [16]. Our previous studies have 
shown that type IX collagen in adult mammalian 
articular cartilage is preferentially located around 
the chondrocytes especially in the deeper zones 
[ 12,181. The immuno-electron microscopy results 
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presented here confirm this distribution and reveal We therefore conclude from these distribution 
that the type IX collagen is associated almost ex- and in vitro fibrillogenesis studies that one possible 
clusively with the small diameter unbanded fibres. function of type IX collagen is the modulation of 
Contrary to previous reports [15], our studies fail- fibre formation of the major collagenous compo- 
ed to show a localisation at fibre intersections. nent of cartilage - type II collagen. 
Although these results appear to be at variance 
with other studies on embryonic chick sternal car- 
tilage where the type IX collagen is reported to be 
more evenly distributed throughout the matrix 
[10,15], the proportion of type IX collagen is 
relatively high in this tissue and the whole of the 
matrix comprises small even-sized fibres. Indeed, 
in other tissues where a relatively high concentra- 
tion of type IX collagen is present, foetal cartilage 
and vitreous humour, predominantly fine col- 
lagenous fibres are seen [17], which is consistent 
with our hypothesis. 
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